Matinas Biopharma (MTNB) Q2 2025 Earnings

15AprConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.25
-0.84
-0.44
-0.03

Details

Expected EPS
-0.78
Actual EPS
N/A
Surprise EPS
0.78
Surprise Percent
+100%

Description

Matinas Biopharma (MTNB) will report earnings of for Q2 2025 on April 15, 2025.

0 Comments

Share your thoughts